MANAGEMENT OF MUCORMYCOSIS IN AYURVEDA: AN EVIDENCE BASED REVIEW
DOI:
https://doi.org/10.70066/jahm.v9i2.432Abstract
Mucormycosis represents a group of life-threatening infections caused by fungi of the order Mucorales of the subphylum Mucoromycotina (formerly known as the class Zygomycetes). Mucormycosis highly invasive and relentlessly progressive, resulting in higher rates of morbidity and mortality than many other infections Mucormycosis is a severe emerging invasive fungal infection that occurs as a consequence of environmental exposure. Those infections are becoming increasingly common yet survival remains very poor. It is a rare disease but increasingly recognized in immune-compromised patients. Out of which 39% in the sinonasal form. In spite of aggressive treatment once detected or diagnosed overall increased mortality rate is reported. The treatment cost is also very high and needs a long course of treatment. Ayurveda has got cost-effective, potent, and broad-spectrum Anti-fungal agents. In this article, preventive guidelines and treatment protocol for mucormycosis are discussed based on the evidence-based data collected from experiential data, experimental and clinical research findings.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Vasant Patil, Madhuri Rodd, Shruti Naik, Maitreyee Kolhapure

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.